focus trial semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 - Kushner - 2020 - Obesity focus semaglutide Ozempic (semaglutide) shows

10.1038/nature24294 229 RamapriyanR.CaetanoM

As no pregnancy or lactation data exist for retatrutide, women who are breastfeeding should not use it

For Mounjaro, across the SURPASS trials in type 2 diabetes, cholelithiasis was reported in 0.6% of tirzepatide-treated patients compared to 0% in the placebo group

This broad inclusion mirrors the real-world patient population that would ultimately receive the medication

That is the population where the benefit-risk calculation makes sense based on current data

Primary care constitutes the foundation of the Swedish healthcare system, though the organization differs between regions